Abstract
Cancer is one of the most recurrent chronic diseases in the Brazilian and worldwide population. In this scenario, areas like nanomedicine and immunotherapy have the most satisfactory clinical results. Currently, studies that encompass their knowledge create new modalities of therapies able to reduce tumor expansion and adverse effects of treatments. As one of the main factors favoring the…